Naloxone Accord-Uk (Naloxone Hydrochloride)

Naloxone, the active ingredient in Naloxone Accord-Uk, is an opioid antagonist presented as a sterile solution for intravenous use. It rapidly reverses the effects of opioid overdose in emergency situations. GNH USA supplies Naloxone Accord-Uk as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Naloxone is an opioid antagonist used in the management of opioid overdose and related emergencies.

- Opioid overdose: rapidly reverses respiratory depression and sedation caused by opioid toxicity. - Acute opioid toxicity: restores consciousness and normal breathing in emergency settings. - Post‑operative opioid excess: counteracts unintended opioid effects after surgery.

Naloxone may cause a range of adverse reactions following intravenous administration.

Common Side Effects: - Injection site pain: mild discomfort at the injection site. - Nausea: feeling of queasiness. - Vomiting: expulsion of stomach contents. - Sweating: increased perspiration. - Tremor: involuntary shaking. - Hypertension: temporary rise in blood pressure.

Serious or Rare Side Effects: - Severe hypertension: marked increase in blood pressure requiring medical attention. - Cardiac arrhythmia: irregular heart rhythm. - Pulmonary edema: fluid accumulation in the lungs. - Anaphylaxis: severe allergic reaction with potential airway compromise.

Naloxone should be used with awareness of specific safety considerations.

- Pregnancy: safety not established; use only if benefit outweighs risk. - Breastfeeding: unknown; consider potential infant exposure. - Renal impairment: no dosage adjustment needed, but monitor patient. - Cardiovascular disease: monitor blood pressure and heart rate. - Concomitant opioid therapy: may precipitate acute withdrawal symptoms. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Naloxone can interact with other substances that affect the central nervous system or cardiovascular system.

Major Interactions (Avoid): - Opioid agonists: may cause abrupt withdrawal. - MAO inhibitors: risk of hypertensive crisis. - Tricyclic antidepressants: potential for severe hypertension.

Moderate Interactions (Monitor Closely): - Benzodiazepines: additive central nervous system depression. - Alcohol: additive central nervous system depression. - CYP3A4 inhibitors: may increase naloxone plasma levels, though effect is minimal.